ATCC, the world’s premier biological materials management and standards organization, today announced a five-year, $87 million award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to support the development of next-generation medical countermeasures (MCMs) to protect Americans from public health security threats such as coronaviruses.
Scoop: CellProthera eyes $30M round for PhIII trial of cell therapy for heart attacks: #Jefferies23
CellProthera plans to raise around $30 million in its first major fundraise to help advance its lead regenerative cell therapy program for patients who have
November 16, 2023